SCIENTIFIC AGENDA

Click here to view program

Immunotherapy in Lung Cancer: TLR9 as a Therapeutic Target
Wilfried Eberhardt, MD

Histone Deacetylase (HDAC) Inhibitors in NSCLC
Johan Vansteenkiste, MD, PhD

Update on New Targets and New Agents in Lung Cancer:
MTOR Inhibitors
Lucio Crino, MD

New Agents in Lung Cancer: VEGF Receptor Inhibitors
Jean-Yves Douillard, MD, PhD

PEMETREXED in Small Cell Lung Cancer
Pieter Postmus, MD, PhD